Lupin Shares Gain 1% as Unit Receives EIR Status from USFDA
Shares of Lupin Ltd were trading in the green and almost 2% higher on 17 December after the company received the EIR from the USFDA. ...
Tag : Establishment Inspection Report
Granules India Shares Slump Despite Securing EIR from USFDA
Shares of Granules India Ltd were trading in the red and almost 1% lower on 15 December despite the company announcing that it has received...
Indoco Remedies Shares Rally 4% on Securing EIR from USFDA
Shares of Indoco Remedies Ltd rallied 4% on 12 December after the company announced receiving an Establishment Inspection Report (EIR) from the US Food and...
Natco Pharma Shares Surge 3% as Hyderabad Unit Gets EIR
Shares of Natco Pharma Ltd surged 3% on Thursday, 18 September, after the company announced that its unit in Hyderabad received EIR from the USFDA. ...
SMS Pharma Shares Skyrocket 10% on EIR from USFDA
Shares of SMS Pharmaceuticals Ltd skyrocketed more than 10% on Thursday, 28 August, after the company received an Establishment Inspection Report (EIR) with a No...
Dr Reddy’s Secured EIR for New York API Facility; Shares Slump 1%
Shares of Dr Reddy’s Laboratories Ltd were trading in the red and 1% lower on 22 July despite the company announcing it had obtained the...
Alembic Pharma Secures EIR from USFDA
Alembic Pharmaceuticals Ltd announced on Wednesday, 18 June, that it received an Establishment Inspection Report (EIR) from the US Food and Drug Administration (USFDA) for...
Zydus Lifesciences Shares Gain 1% on EIR from USFDA
Shares of Zydus Lifesciences Ltd were trading in the green and 1% higher on 12 June after the company secured the Establishment Inspection Report (EIR)...
Shilpa Medicare Shares Surge 5% on Securing EIR from USFDA
Shares of Shilpa Medicare Ltd were trading almost 5% higher on 15 May after the company secured an Establishment Inspection Report (EIR) from the United...
Alembic Pharma Shares Soar 3% as Panelav Unit Secures EIR
Alembic Pharmaceuticals Ltd stock price rose 3% in early trading on 30 April following the establishment inspection report (EIR) for its Panelav-based oncology formulation facility....